Statins therapy also suppresses the activation of NADPH oxidase [61] and uncoupling of eNOS as well as subsequent endothelial dysfunction in animal models [62], all of which contribute to the beneficial antioxidant profile of statins [63]. This evidence concerns the gene NOS3 and endothelial dysfunction.